Te‐Sheng Chang

939 total citations
50 papers, 678 citations indexed

About

Te‐Sheng Chang is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Te‐Sheng Chang has authored 50 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hepatology, 26 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in Te‐Sheng Chang's work include Hepatitis C virus research (27 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis B Virus Studies (15 papers). Te‐Sheng Chang is often cited by papers focused on Hepatitis C virus research (27 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis B Virus Studies (15 papers). Te‐Sheng Chang collaborates with scholars based in Taiwan, United States and United Kingdom. Te‐Sheng Chang's co-authors include Shui‐Yi Tung, Yung‐Yu Hsieh, Kuo‐Liang Wei, Chien‐Heng Shen, Yen‐Hua Huang, Wei‐Ming Chen, Cheng‐Shyong Wu, Sheng‐Nan Lu, Chao‐Hung Hung and Yung‐Che Kuo and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Te‐Sheng Chang

50 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Te‐Sheng Chang Taiwan	14	305	278	154	109	109	50	678
Lubiao Chen China	12	202 0.7×	167 0.6×	181 1.2×	91 0.8×	80 0.7×	37	470
Shuangshuang Zhao China	11	268 0.9×	180 0.6×	180 1.2×	77 0.7×	67 0.6×	21	647
Kai‐Henrik Peiffer Germany	14	463 1.5×	468 1.7×	133 0.9×	62 0.6×	92 0.8×	47	734
Takahisa Sakai Japan	15	252 0.8×	288 1.0×	243 1.6×	106 1.0×	82 0.8×	41	760
Chan Ran You South Korea	14	426 1.4×	516 1.9×	70 0.5×	162 1.5×	113 1.0×	30	776
Francesco Santopaolo Italy	15	317 1.0×	255 0.9×	206 1.3×	80 0.7×	37 0.3×	44	616
Luca Maroni Italy	17	247 0.8×	320 1.2×	193 1.3×	157 1.4×	48 0.4×	41	749
Mei‐Hsuan Lee Taiwan	16	556 1.8×	518 1.9×	99 0.6×	60 0.6×	67 0.6×	43	791
José María Vera-Cruz Mexico	10	282 0.9×	250 0.9×	124 0.8×	45 0.4×	47 0.4×	13	563

Countries citing papers authored by Te‐Sheng Chang

Since Specialization

Citations

This map shows the geographic impact of Te‐Sheng Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te‐Sheng Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te‐Sheng Chang more than expected).

Fields of papers citing papers by Te‐Sheng Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Te‐Sheng Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te‐Sheng Chang. The network helps show where Te‐Sheng Chang may publish in the future.

Co-authorship network of co-authors of Te‐Sheng Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Te‐Sheng Chang. A scholar is included among the top collaborators of Te‐Sheng Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Te‐Sheng Chang. Te‐Sheng Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Te‐Sheng, Chien‐Heng Shen, Liang-Mou Kuo, et al.. (2024). Survival benefit of sequential curative treatment for TACE suitable BCLC stage B HCC patients. Scientific Reports. 14(1). 22588–22588. 2 indexed citations

Chen, Chien‐Hung, et al.. (2024). Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas. Journal of the Formosan Medical Association. 123(5). 613–619. 2 indexed citations

Hsieh, Yung‐Yu, Wei‐Ming Chen, Chien‐Heng Shen, et al.. (2024). Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan. Diagnostics. 14(2). 213–213. 1 indexed citations

Chen, Chun‐Hsien, Chien‐Heng Shen, Kuo‐Liang Wei, et al.. (2023). Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy. Diagnostics. 13(3). 473–473. 1 indexed citations

Hsieh, Yung‐Yu, Wei‐Ming Chen, Te‐Sheng Chang, et al.. (2023). Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis. Viruses. 15(1). 252–252. 3 indexed citations

Lu, Chung‐Kuang, Yung‐Yu Hsieh, Shui‐Yi Tung, et al.. (2022). Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting. PLoS ONE. 17(8). e0272567–e0272567. 2 indexed citations

Chang, Te‐Sheng, et al.. (2022). Non-B, Non-C Hepatocellular Carcinoma in an HBV- and HCV-Endemic Area: A Community-Based Prospective Longitudinal Study. Viruses. 14(5). 984–984. 6 indexed citations

Chang, Te‐Sheng, et al.. (2021). Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance. International Journal of Molecular Sciences. 22(3). 1258–1258. 24 indexed citations

Hsieh, Yung‐Yu, Shui‐Yi Tung, Hung-Yu Pan, et al.. (2021). Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients. World Journal of Gastroenterology. 27(42). 7311–7323. 37 indexed citations

10.

Tung, Shui‐Yi, Kuo‐Liang Wei, Yung‐Yu Hsieh, et al.. (2021). Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan. Scientific Reports. 11(1). 13543–13543. 16 indexed citations

11.

Chang, Te‐Sheng, Chung‐Kuang Lu, Yung‐Yu Hsieh, et al.. (2020). 2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis. International Journal of Molecular Sciences. 21(16). 5901–5901. 12 indexed citations

12.

Chang, Te‐Sheng, Chao‐Hung Hung, Wei‐Ming Chen, et al.. (2020). Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening. Journal of the Formosan Medical Association. 120(2). 847–853. 3 indexed citations

13.

Chen, Wei‐Ming, Kuo‐Liang Wei, Shui‐Yi Tung, et al.. (2020). High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy. Journal of the Formosan Medical Association. 119(11). 1593–1600. 4 indexed citations

14.

Li, Wei, et al.. (2020). Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach. BMC Infectious Diseases. 20(1). 737–737. 7 indexed citations

15.

Tung, Shui‐Yi, Kuo‐Liang Wei, Chien‐Hung Chen, et al.. (2020). Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C. PLoS ONE. 15(3). e0229994–e0229994. 13 indexed citations

16.

Tung, Shui‐Yi, Kuo‐Liang Wei, Chien‐Heng Shen, et al.. (2019). Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin. Journal of the Formosan Medical Association. 119(1). 532–537. 3 indexed citations

17.

Huang, Kuo‐Chin, et al.. (2016). Distribution of Fatal Vibrio Vulnificus Necrotizing Skin and Soft-Tissue Infections. Medicine. 95(5). e2627–e2627. 37 indexed citations

18.

Cheng, Yeong-Hsiang, et al.. (2015). Bupivacaine induces apoptosis through caspase-dependent and -independent pathways in canine mammary tumor cells. Research in Veterinary Science. 100. 232–238. 1 indexed citations

19.

Hsieh, Yung‐Yu, Chien‐Heng Shen, Wen‐Shih Huang, et al.. (2014). Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells. Journal of Biomedical Science. 21(1). 59–59. 68 indexed citations

20.

Cross, Troy J., Vincenza Calvaruso, S. Maimone, et al.. (2009). Prospective comparison of Fibroscan, King’s score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. Journal of Viral Hepatitis. 17(8). 546–554. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact